Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ghmm who wrote (327)	9/17/2008 2:23:01 PM
From: rkrw	Read Replies (2) of 684

130 is a bad exaggeration. But there are a lot. 35 listed below and I'm sure I'm missing some. Not sure what Freiman's point was, his stock is below cash because no one thinks Viprinex will work and Namenda royalties expire soon. On the plus side, major HR shot if Viprinex surprises. As of mid day today, cash as of end q2: Vion Agix Nuvo Orxe Osci Altu Vnda Novc Telk Kerx Ymi Tptx Nrgn Inhx Panc Rdyn Nstr Neol Cycc Crgn Mnov Gnlb Ntii Maxy Sppi Crtx Avrx Ttp Supg Enmd Pcop Thld Isv Nktr Adlr

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next